Related Experiment Video
Updated: Jan 12, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
A Decade of Pediatric Ventricular Assist Device Support in Colombia, a Middle-Income Country
Javier Castro1, Melina Acevedo1, Angelica Ortiz1
1International Hospital of Colombia, Floridablanca, Colombia.
Insights
Pediatric ventricular assist device (VAD) use in Colombia shows 81% survival to transplant, despite challenges. Left ventricular assist devices (LVAD) improved post-transplant survival compared to biventricular assist devices (BiVAD).
Area of Science:
- Pediatric Cardiology
- Mechanical Circulatory Support
- Transplant Surgery
Background:
- Heart transplantation is limited by organ availability, especially for pediatric patients.
- Ventricular assist devices (VADs) offer a critical bridge to transplant for pediatric end-stage heart failure.
- The International Hospital of Colombia has extensive experience with paracorporeal VADs in children.
Purpose of the Study:
- To evaluate the outcomes of pediatric patients receiving VAD support in Colombia.
- To identify challenges and successes in implementing VAD technology in a middle-income country.
- To compare outcomes between left ventricular assist devices (LVAD) and biventricular assist devices (BiVAD).
Main Methods:
- Retrospective analysis of 26 pediatric patients who received VAD support between 2012 and 2023.
- Data collected on patient demographics, VAD type, duration of support, complications, and transplant outcomes.
- Comparison of survival rates between LVAD and BiVAD support.
Main Results:
- The majority of patients (77%) had dilated cardiomyopathy, with a median age of 8.5 years.
- The median duration of VAD support was 50.5 days.
- Overall survival to VAD support was 81%, with 81% of survivors undergoing successful transplantation.
- Neurological injury was the most frequent complication (69%).
- LVAD support was associated with higher post-transplant survival compared to BiVAD.
Conclusions:
- Despite resource constraints in middle-income countries, significant patient survival can be achieved with VAD support.
- Targeted improvements in resource allocation and technology access can further enhance outcomes for pediatric VAD patients.
- VADs are a viable option for pediatric end-stage heart failure, bridging patients to transplantation.
Background:
Heart transplantation is the main treatment for refractory end-stage heart failure in patients of all ages, but its use is limited by the availability of organs, especially in pediatric populations. The International Hospital of Colombia has been a pioneer and the single center with the capability in the country for providing ventricular assist device (VAD) support using the CentriMag/PediMag-Levitronix paracorporeal VAD for pediatric patients awaiting transplant, with over a decade of experience albeit with many challenges.
Methods:
This retrospective study examines outcomes from 26 pediatric patients who received VAD support between 2012 and 2023.
Results:
Most patients were diagnosed with dilated cardiomyopathy (n = 20, 77%), had an average age of 8.5 years (SD 5.3), and ranged in weight from 5 to 59 kg. The median duration of VAD support was 50.5 days, with 17 (81%) of surviving patients (n = 21), successfully undergoing transplantation. Neurological injury was the most common complication, affecting 69% of patients. The overall survival rate to VAD support was 81% and patients with left ventricular assist devices (LVAD) showed a higher post-transplant survival rate compared to those with biventricular assist devices (BiVAD).
Conclusions:
This comparative analysis highlights the challenges faced in Colombia, particularly in implementing advanced medical technologies in middle-income countries. Despite these constraints, the study demonstrates notable patient survival, suggesting that targeted efforts to improve resource allocation and technology access could further enhance results.
More Related Videos
07:39Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Cardiopulmonary Resuscitation III: AED Use
Cardiomyopathy V: Interprofessional Care
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Mechanical Ventilation I: Indication and Settings
Cardiac Catheterization II: Right Heart Catheterization